Although the hepcidin-MetS association has been established for the first time, more studies are needed for validation and further elucidation of the mechanisms relating hepcidin to other iron biomarkers, including Hb, in the complex pathophysiology of the MetS. This evidence concerns the gene GSTM1 and metabolic syndrome.